Please login to the form below

briefing

This page shows the latest briefing news and features for those working in and with pharma, biotech and healthcare.

Bluebird puts €1.57m price on gene therapy Zynteglo

The US biotech revealed the price of Zynteglo (autologous CD34+ cells encoding βA-T87Q-globin gene) to Pharma Market Europe in an briefing with its head of Europe, Andrew Obenshain, ahead

Latest news

Deal or no deal? Brexit battlelines drawn in Tory leadership bids

Now, with the new crop of MEPs en route to Brussels and Strasbourg, the BioIndustry Association (BIA) is offering a briefing for them on the key issues facing the UK life
One hit, one miss as FDA panel votes on Daiichi’s cancer drugs

Quizartinib’s failure to clear the panel wasn’t a complete surprise, as a briefing document published by the FDA reviewer ahead of the committee meeting revealed the agency had misgivings
FDA panel backs J&J’s new-class antidepressant

Ordinarily that would not be enough to support approval, but the FDA said in briefing documents published ahead of the meeting it considered a third withdrawal ‘maintenance of effect’ study to
FDA adcomm split on Sanofi’s type 1 diabetes drug

Lexicon’s trials of the drug in type 1 diabetes showed an eight-fold increase in DKA in Zynquista-treated patients compared to placebo, according to FDA briefing documents (PDF) published
Evenity back on track with FDA panel blessing in osteoporosis

Importantly for Amgen, FDA briefing documents published ahead of the advisory committee meeting also took a neutral tone on the drug’s safety, and with Japan’s regulators also happy with

More from news
Approximately 1 fully matching, plus 124 partially matching documents found.

Latest Intelligence

The UK’s new medicines pricing deal – opportunities and risks for pharma

This includes briefing committees on the types of uncertainty and those that have the most significant impact on cost-effectiveness.
Deal Watch - May 2017

premium. According to a Financial Times report, this deal comes only months after BD at an analyst briefing stated it was seeking to reduce its leverage to three times annual cash
Pharma Perspectives: The agency selection process (part 2)

For me an ideal selection process should always start with a quality brief and offer all - or none - of the agencies the same chance for an additional briefing or Q&A. ... Success also stems from brand teams investing time in quality briefings.
Pharma Perspectives: The agency selection process (part 1)

Once the process is completed, how do you ensure success? Sadly, working relationships often falter or fail because of an inadequate briefing or engagement following completion of the selection process.
Tracking comms trends: Applying a global brief to a local market

From multi-disciplinary teamwork to pharma’s reputation, value and access to global briefs, our contributors tackle some of the key topics in communications today

More from intelligence
Approximately 1 fully matching, plus 18 partially matching documents found.

Latest appointments

mXm Group bolsters its editorial and account handing teams

Chris Watson joins the agency as its editorial manager after previously holding a number of senior editorial and medical writing positions at Springer Healthcare, Touch Briefings, Mudskipper and Elsevier.
JPA strengthens PR offering

He will work on briefing and strategy documents, event organisation and media outreach.

More from appointments
Approximately 0 fully matching, plus 2 partially matching documents found.

Latest from PMHub

Lucid Group’s cinematic performance at its company team briefing

The Electric Cinema on Portobello Road, London, played host to Lucid’s first new-look quarterly team briefing, during which all UK employees gathered. ... At the end of the briefing, everyone had the opportunity to network, relax, reflect and get
What Would Jeremy Do? : Assessing the impact of a Corbyn-led Labour government

GK Strategy are delighted to announce the launch our latest briefing paper entitled ‘What Would Jeremy Do?
Synergy Vision

Congress/symposia. Programme development, faculty selection, logistical management, satellite symposia, exhibition booths, meet-the-experts, apps, briefing meetings, poster/oral presentation, content development and competitor reports.
Blog: 5 ingredients: Multichannel marketing, simplified

budget for media spend. – employ a smart media agency. – involve the media agency from the briefing stage. –
10 tips on Transcreation

7. Briefing. All of the above (and few other points such as linguistic insights and brand vision) form the brief for copywriters. ... The briefing should be given time and careful consideration as a properly written brief is already half the job done.

More from PMHub
Approximately 0 fully matching, plus 15 partially matching documents found.

Featured jobs

Strategic Planner, Healthcare Advertising Agency: Salary TBC

Senior Account Manager > Account Director - London - Medical ...: Salary TBC

Senior Medical Writer, Healthcare Advertising Agency: £45, 000 – £50, 000

FREELANCE Medical Writer (Initial 2/ 3 months term) - London Off...: Excellent Daily Rate

Account Director - Healthcare Advertising - London - 2 DAYS HOME...: £50000 - £70000

Senior Account Executive – Account Manager – Healthcare Advertis...: £32000 - £43000 Bonus Benfits

Account Director – UK Office: Excellent salary and benefits

FREELANCE Account Director – Healthcare Advertising – London – 3...: Competitive Daily Rates

Account Director - Medical Communications - London / South East: Excellent Salary and Benefits on offer

Account Director, Healthcare Communications: Salary TBC

Account Director – London based Medical Communications Agency: Excellent Remuneration Package

Subscribe to our email news alerts

PMHub

Add my company

GCI Health

GCI Health London is a young, vibrant powerhouse in the European industry with a mission to redefine healthcare communications, starting...

Latest intelligence

The relevance of patient perspectives to value: Exploring the evolution of patient involvement in health technology assessment, and the role of the patient voice in market access....
How is the NHS Long-term Plan being put into action?: Steve How, Paul Midgley and Oli Hudson, of Wilmington Healthcare, explore some of the changes that have occurred since the plan was published...
The evolution of real-world studies: How industry and regulators are using real-world data...